| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/05/1997 | CN1142188A 人生长激素 Human Growth Hormone |
| 02/05/1997 | CN1142187A Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/05/1997 | CN1141810A Viral vaccine |
| 02/05/1997 | CA2182637A1 Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing them |
| 02/04/1997 | US5599844 Administering agent to elevate level of transforming growth factor beta |
| 02/04/1997 | US5599719 Method for isolating biomolecules from a biological sample with linear polymers |
| 02/04/1997 | US5599707 Human prohibitin DNA |
| 02/04/1997 | US5599693 Culture product |
| 02/04/1997 | US5599692 Antigenic polypeptides of Taenia ovis |
| 02/04/1997 | US5599691 Herpes simplex virus as a vector |
| 02/04/1997 | US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use |
| 02/04/1997 | US5599677 Immunoassays for prostate specific antigen |
| 02/04/1997 | US5599665 Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection |
| 02/04/1997 | US5599552 Biodegradable polymer composition |
| 02/04/1997 | US5599545 Mycobacterium as adjuvant for antigens |
| 02/04/1997 | US5599544 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1997 | US5599543 Preventing malaria |
| 02/04/1997 | US5599542 Diagnosis, treatment and vaccine for malaria; induction of antibodies that attack plasmodium in the schizont stage |
| 02/04/1997 | US5599541 Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of living bacteria of the Mycobacterium tuberculosis complex and its applications |
| 02/04/1997 | US5599539 Administering avian antitoxin |
| 02/04/1997 | US5599537 Salmonella virulence genes |
| 02/04/1997 | CA2071425C Prophylactic/therapeutic composition for disseminated intravascular coagulation, or chronic respiratory tract infectious disease |
| 02/04/1997 | CA1338888C Matrix with immunomodulating activity |
| 01/30/1997 | WO1997003360A1 HELICOBACTER VACCINE ANTIGEN RECOGNIZED BY A PROTECTIVE MONOCLONAL ANTIBODY (IgG 50) |
| 01/30/1997 | WO1997003359A1 Helicobacter clpb |
| 01/30/1997 | WO1997003203A2 Generation of immune responses to prostate-specific antigen (psa) |
| 01/30/1997 | WO1997003199A1 Herpes simplex virus glycoprotein d variants |
| 01/30/1997 | WO1997003192A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | WO1997003187A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | WO1997003186A2 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1997002838A1 Polymerized vaccines |
| 01/30/1997 | WO1997002837A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 01/30/1997 | WO1997002836A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | WO1997002835A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | WO1997002810A2 Polymeric lamellar substrate particles for drug delivery |
| 01/30/1997 | DE19527552A1 Transketolase-verwandtes-Protein Transketolase-related protein |
| 01/30/1997 | DE19527129A1 Arzneimittel enthaltend wenigstens einen Teil des UL84-Proteins des Cytomegalovirus, Verwendung von Polypeptiden entsprechend der Aminosäuresequenz des UL84-Proteins und Verfahren zur Einführung von UL84 in Zielzellen Medicament comprising at least one part of the UL84 protein of cytomegalovirus, use of polypeptides according to the amino acid sequence of the UL84 protein and method for introducing into target cells UL84 |
| 01/30/1997 | CA2235718A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226490A1 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 01/30/1997 | CA2226392A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | CA2226362A1 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 01/30/1997 | CA2226339A1 Clostridium difficile toxins as mucosal adjuvants |
| 01/30/1997 | CA2226255A1 Chromosome 1 gene and gene products related to alzheimer's disease |
| 01/30/1997 | CA2223884A1 Polymeric lamellar substrate particles for drug delivery |
| 01/29/1997 | EP0756005A1 Gene coding for adseverins |
| 01/29/1997 | EP0755943A1 Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus |
| 01/29/1997 | EP0755684A1 Vaccine conjugate |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755517A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 01/29/1997 | EP0755444A1 MOLECULAR CLONING AND EXPRESSION OF A $g(g)-INTERFERON INDUCIBLE ACTIVATOR OF THE PROTEASOME |
| 01/29/1997 | EP0755440A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 01/29/1997 | EP0755403A1 Method of separating protective components of bordetella pertussis |
| 01/29/1997 | EP0755266A1 An adjuvant |
| 01/29/1997 | EP0755263A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/29/1997 | EP0755257A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
| 01/29/1997 | EP0693119B1 Needleless syringe using supersonic gas flow for particle delivery |
| 01/29/1997 | EP0493446B1 Treatment of autoimmune disease |
| 01/28/1997 | US5597908 Anti-apolipoprotein |
| 01/28/1997 | US5597896 Retrovirus human immunodeficiency virus type 2(HIV2), capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
| 01/28/1997 | US5597895 Inhibiting the expression of hiv virus |
| 01/28/1997 | US5597726 Monoclonal antibodies reactive with a human atheroma associated antigen |
| 01/28/1997 | US5597721 Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease |
| 01/28/1997 | US5597710 Genetic engineering |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597708 Cloning of a malarial gene |
| 01/28/1997 | US5597572 Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method |
| 01/28/1997 | US5597571 Eimeria antigenic composition which elicits antibodies against avian coccidiosis |
| 01/28/1997 | US5597570 Protein recognized by antibodies raised against native P28 of schistosoma mansoni |
| 01/28/1997 | US5597569 Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica |
| 01/28/1997 | US5597567 Blocking cell adhesion molecules and treating animals with ocular inflammation |
| 01/28/1997 | US5597386 Inorganic pigments, water soluble color and polymer carrier |
| 01/28/1997 | CA1338879C Mastitis vaccine |
| 01/26/1997 | CA2182032A1 Peptide recognizable by antibodies recognizing hepatitis c virus c33 antigen |
| 01/23/1997 | WO1997002355A1 Recombinant mva virus, and the use thereof |
| 01/23/1997 | WO1997002348A1 Immunogenic detoxified mutant of cholera toxins |
| 01/23/1997 | WO1997002347A1 A human map kinase homolog |
| 01/23/1997 | WO1997002344A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002283A1 Helicobacter antigens |
| 01/23/1997 | WO1997002280A1 Breast specific genes and proteins |
| 01/23/1997 | WO1997002052A1 Method for detecting or monitoring the effectiveness of treatment of t cell mediated diseases |
| 01/23/1997 | WO1997002045A1 Therapeutic agents and autoimmune diseases |
| 01/23/1997 | WO1997002044A1 Preservative for a vaccine composition |
| 01/23/1997 | WO1997002016A1 Preparations and methods for the treatment of t cell mediated diseases |
| 01/23/1997 | WO1996041877A3 Malarial pre-erythrocytic stage polypeptide molecules |
| 01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
| 01/23/1997 | WO1996040944A3 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 01/23/1997 | WO1996040940A3 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 01/23/1997 | WO1996040915A3 Novel ctla4/cd28 ligands and uses therefor |
| 01/23/1997 | WO1996040777A3 Synthetic peptides and pharmaceutical compositions comprising them |
| 01/23/1997 | WO1996040250A3 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 01/23/1997 | WO1996040077A3 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 01/23/1997 | CA2225824A1 Breast specific genes and proteins |
| 01/23/1997 | CA2223825A1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 01/23/1997 | CA2198729A1 A novel human map kinase homolog |
| 01/22/1997 | EP0754704A2 Synthetic antigens for the detection of antibodies to hepatitis C virus |